Standard BioTools Releases the X9 Real-Time PCR System, Its Most Productive and Flexible Solution Yet
SOUTH SAN FRANCISCO, Calif., Oct. 06, 2022 (GLOBE NEWSWIRE) — Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health™ – today announced the launch of the X9™ Real-Time PCR System, an innovative high-capacity genomics…
The microfluidics-based system accommodates scalable throughputs to address specific and evolving project needs. The X9 Real-Time PCR System marks a significant advancement in genomics technology, offering researchers a versatile and high-performance tool for their most demanding projects.
With a focus on productivity and flexibility, the X9 Real-Time PCR System is designed to meet the needs of modern genomics research. Its scalable throughputs allow researchers to easily adjust the system to the specific requirements of their projects, providing a streamlined workflow and increased efficiency.
Standard BioTools Inc. has a reputation for delivering innovative solutions that empower researchers to accelerate breakthroughs in human health. The launch of the X9 Real-Time PCR System further solidifies the company’s commitment to providing cutting-edge tools that drive progress in genomics research.
How Will This Affect Me?
As a researcher in the field of genomics, the launch of the X9 Real-Time PCR System will have a significant impact on your work. This innovative system offers increased productivity and flexibility, allowing you to take on more complex projects and streamline your workflow. With its scalable throughputs, the X9 Real-Time PCR System provides a versatile solution that can be tailored to meet the specific needs of your research.
How Will This Affect the World?
The release of the X9 Real-Time PCR System by Standard BioTools Inc. represents a major advancement in genomics technology that will have far-reaching implications for the world of research and healthcare. By providing researchers with a high-capacity and flexible tool, this system has the potential to accelerate breakthroughs in human health and drive progress in the field of genomics. The impact of this innovation could lead to new discoveries, improved treatments, and better outcomes for patients worldwide.
Conclusion
The launch of the X9 Real-Time PCR System by Standard BioTools Inc. is a significant development in genomics technology, offering researchers a high-capacity and flexible solution to meet their evolving project needs. With its scalable throughputs and focus on productivity, this system has the potential to drive breakthroughs in human health and advance the field of genomics research. As researchers and healthcare professionals continue to explore the capabilities of the X9 Real-Time PCR System, we can expect to see exciting advancements that benefit both individuals and society as a whole.
